IGF2-induced hypoglycemia unresponsive to everolimus

QJM. 2014 Apr;107(4):297-300. doi: 10.1093/qjmed/hcr249. Epub 2011 Dec 14.

Authors

T I M Korevaar¹, F Ragazzoni, A Weaver, N Karavitaki, A B Grossman

Affiliation

¹ Oxford Centre for Diabetes, Endocrinology and Metabolism, University of Oxford, Headington, Oxford OX3 7LE, UK. ashley.grossman@ocdem.ox.ac.uk.

PMID: 22171014
DOI: 10.1093/qjmed/hcr249

No abstract available

Publication types

Case Reports

MeSH terms

Adrenal Cortex Neoplasms / complications
Adrenal Cortex Neoplasms / diagnostic imaging
Adrenal Cortex Neoplasms / drug therapy
Adrenal Cortex Neoplasms / metabolism
Adrenocortical Carcinoma / complications
Adrenocortical Carcinoma / diagnostic imaging
Adrenocortical Carcinoma / drug therapy
Adrenocortical Carcinoma / metabolism
Adult
Antineoplastic Agents / therapeutic use
Everolimus
Female
Humans
Hypoglycemia / drug therapy
Hypoglycemia / etiology*
Insulin-Like Growth Factor II / metabolism
Insulin-Like Growth Factor II / physiology*
Sirolimus / analogs & derivatives*
Sirolimus / therapeutic use
Tomography, X-Ray Computed

Substances

Antineoplastic Agents
Insulin-Like Growth Factor II
Everolimus
Sirolimus